TY - JOUR
T1 - Antimalarial activity of tetrahydro-β-carbolines targeting the ATP binding pocket of the Plasmodium falciparum heat shock 90 protein
AU - Eagon, Scott
AU - Hammill, Jared T.
AU - Bach, Jordan
AU - Everson, Nikalet
AU - Sisley, Tyler A.
AU - Walls, Michael J.
AU - Durham, Sierra
AU - Pillai, Dylan R.
AU - Falade, Mofolusho O.
AU - Rice, Amy L.
AU - Kimball, Joshua J.
AU - Lazaro, Horacio
AU - DiBernardo, Celine
AU - Kiplin Guy, R.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/11/1
Y1 - 2020/11/1
N2 - A series of tetrahydro-β-carboline derivatives of a lead compound known to target the heat shock 90 protein of Plasmodium falciparum were synthesized and assayed for both potency against the parasite and toxicity against a human cell line. Using a rationalized structure based design strategy, a new lead compound with a potency two orders of magnitude greater than the original lead compound was found. Additional modeling of this new lead compound suggests multiple avenues to further increase potency against this target, potentially paving the path for a therapeutic with a mode of action different than any current clinical treatment.
AB - A series of tetrahydro-β-carboline derivatives of a lead compound known to target the heat shock 90 protein of Plasmodium falciparum were synthesized and assayed for both potency against the parasite and toxicity against a human cell line. Using a rationalized structure based design strategy, a new lead compound with a potency two orders of magnitude greater than the original lead compound was found. Additional modeling of this new lead compound suggests multiple avenues to further increase potency against this target, potentially paving the path for a therapeutic with a mode of action different than any current clinical treatment.
KW - Malaria
KW - Plasmodium falciparum
KW - Structure activity relationship
KW - Structure based design
KW - Tetrahydro-β-carbolines
UR - http://www.scopus.com/inward/record.url?scp=85089795315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089795315&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2020.127502
DO - 10.1016/j.bmcl.2020.127502
M3 - Article
C2 - 32822760
AN - SCOPUS:85089795315
SN - 0960-894X
VL - 30
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 21
M1 - 127502
ER -